| Coordination and management of multisite complementary and alternative medicine (CAM) therapies: experience from a multisite reflexology intervention trial. | |
| | |
MedLine Citation:
|
PMID: 21664296 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Multisite randomized clinical trials allow for increased research collaboration among investigators and expedite data collection efforts. As a result, government funding agencies typically look favorably upon this approach. As the field of complementary and alternative medicine (CAM) continues to evolve, so do increased calls for the use of more rigorous study design and trial methodologies, which can present challenges for investigators. PURPOSE: To describe the processes involved in the coordination and management of a multisite randomized clinical trial of a CAM intervention. METHODS: Key aspects related to the coordination and management of a multisite CAM randomized clinical trial are presented, including organizational and site selection considerations, recruitment concerns and issues related to data collection and randomization to treatment groups. Management and monitoring of data, as well as quality assurance procedures are described. Finally, a real world perspective is shared from a recently conducted multisite randomized clinical trial of reflexology for women diagnosed with advanced breast cancer. RESULTS: The use of multiple sites in the conduct of CAM-based randomized clinical trials can provide an efficient, collaborative and robust approach to study coordination and data collection that maximizes efficiency and ensures the quality of results. CONCLUSIONS: Multisite randomized clinical trial designs can offer the field of CAM research a more standardized and efficient approach to examine the effectiveness of novel therapies and treatments. Special attention must be given to intervention fidelity, consistent data collection and ensuring data quality. Assessment and reporting of quantitative indicators of data quality should be required. |
| | |
Authors:
|
Mohammad H Rahbar; Gwen Wyatt; Alla Sikorskii; David Victorson; Manouchehr Ardjomand-Hessabi |
Related Documents
:
|
17691796 - A practical, enantioselective synthetic route to a key precursor to the tetracycline an... 15679896 - The pharmaceutical benefits scheme 2003-2004. 10260566 - The relationship among perceptual similarity, sex, and performance ratings in manager-s... 12407476 - Did the london initiative zone investment programme affect general practice structure a... 3123296 - Writing a statement of philosophy of management. 7428396 - Nasotracheal intubations in the emergency department. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-06-02 |
Journal Detail:
|
Title: Contemporary clinical trials Volume: 32 ISSN: 1559-2030 ISO Abbreviation: Contemp Clin Trials Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-08-01 Completed Date: 2011-12-06 Revised Date: 2012-02-06 |
Medline Journal Info:
|
Nlm Unique ID: 101242342 Medline TA: Contemp Clin Trials Country: United States |
Other Details:
|
Languages: eng Pagination: 620-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Epidemiology and Biostatistics, The University of Texas School of Public Health at Houston, Houston, TX 77030, United States. Mohammad.H.Rahbar@uth.tmc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Breast Neoplasms
/
drug therapy* Chi-Square Distribution Clinical Trials as Topic* Complementary Therapies* Female Humans Information Dissemination / methods Massage* Multicenter Studies as Topic Research Design |
| Grant Support | |
ID/Acronym/Agency:
|
R01 CA104883/CA/NCI NIH HHS; UL1 RR024148/RR/NCRR NIH HHS; UL1 RR024148-03/RR/NCRR NIH HHS; UL1 RR024148-04/RR/NCRR NIH HHS; UL1 RR024148-05/RR/NCRR NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin ...
Next Document: Analysis of the compliance of informed consent documents with good clinical practice guideline.